Literature DB >> 10941829

Elevation of IL-18 in human sepsis.

S R Grobmyer1, E Lin, S F Lowry, D E Rivadeneira, S Potter, P S Barie, C F Nathan.   

Abstract

Interleukin-18 (IL-18) is a recently identified immunoregulatory cytokine that shares biochemical features with IL-1beta and acts in part by inducing interferon-gamma (IFN-gamma). Endotoxic bacterial lipopolysaccharide (LPS) (1 or 2 ng/kg) was insufficient to increase plasma IL-18 in five healthy adults measured 3, 12, and 24 hr following challenge. In contrast, in the first 96 hr of admission to the surgical intensive care unit, mean maximal serum IL-18 was elevated (1,122 +/- 259 pg/ml) in nine septic patients compared to six healthy adults (191 +/- 42 pg/ml), P < 0.01). Serum IL-18 concentrations in septic patients did not correlate with other measured inflammatory mediators: tumor necrosis factor, IL-6, IL-10, or secretory leukocyte protease inhibitor. Therefore, IL-18 circulates in healthy adults and is a component of the human systemic inflammatory response. Further, stimuli other than LPS may induce IL-18 production in vivo in human sepsis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10941829     DOI: 10.1023/a:1006641630904

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  19 in total

1.  Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia.

Authors:  S R Grobmyer; P S Barie; C F Nathan; M Fuortes; E Lin; S F Lowry; C D Wright; M J Weyant; L Hydo; F Reeves; M U Shiloh; A Ding
Journal:  Crit Care Med       Date:  2000-05       Impact factor: 7.598

2.  Ischemia/reperfusion-induced IFN-gamma up-regulation: involvement of IL-12 and IL-18.

Authors:  M A Daemen; C van't Veer; T G Wolfs; W A Buurman
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

3.  Characterization of anti-human interleukin-18 (IL-18)/interferon-gamma-inducing factor (IGIF) monoclonal antibodies and their application in the measurement of human IL-18 by ELISA.

Authors:  M Taniguchi; K Nagaoka; T Kunikata; T Kayano; H Yamauchi; S Nakamura; M Ikeda; K Orita; M Kurimoto
Journal:  J Immunol Methods       Date:  1997-08-07       Impact factor: 2.303

Review 4.  Biologic control of injury and inflammation: much more than too little or too late.

Authors:  X Guirao; S F Lowry
Journal:  World J Surg       Date:  1996-05       Impact factor: 3.352

5.  Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells.

Authors:  A J Puren; G Fantuzzi; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

6.  Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response.

Authors:  D Novick; S H Kim; G Fantuzzi; L L Reznikov; C A Dinarello; M Rubinstein
Journal:  Immunity       Date:  1999-01       Impact factor: 31.745

7.  A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock.

Authors:  H Okamura; K Nagata; T Komatsu; T Tanimoto; Y Nukata; F Tanabe; K Akita; K Torigoe; T Okura; S Fukuda
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

8.  Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure.

Authors:  R M Roumen; T Hendriks; J van der Ven-Jongekrijg; G A Nieuwenhuijzen; R W Sauerwein; J W van der Meer; R J Goris
Journal:  Ann Surg       Date:  1993-12       Impact factor: 12.969

9.  Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia.

Authors:  T van der Poll; S M Coyle; K Barbosa; C C Braxton; S F Lowry
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

Review 10.  Interleukin-18: perspectives on the newest interleukin.

Authors:  M T Gillespie; N J Horwood
Journal:  Cytokine Growth Factor Rev       Date:  1998-06       Impact factor: 7.638

View more
  27 in total

Review 1.  Biomarker discovery and development in pediatric critical care medicine.

Authors:  Jennifer M Kaplan; Hector R Wong
Journal:  Pediatr Crit Care Med       Date:  2011-03       Impact factor: 3.624

2.  The Roles of Mitochondrial Damage-Associated Molecular Patterns in Diseases.

Authors:  Kiichi Nakahira; Shu Hisata; Augustine M K Choi
Journal:  Antioxid Redox Signal       Date:  2015-08-17       Impact factor: 8.401

3.  Inflammasome gene profile is modulated in septic patients, with a greater magnitude in non-survivors.

Authors:  K F Esquerdo; N K Sharma; M K C Brunialti; G L Baggio-Zappia; M Assunção; L C P Azevedo; A T Bafi; R Salomao
Journal:  Clin Exp Immunol       Date:  2017-04-20       Impact factor: 4.330

Review 4.  Pathophysiology and treatment of septic shock in neonates.

Authors:  James L Wynn; Hector R Wong
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

5.  Inflammasome-regulated cytokines are critical mediators of acute lung injury.

Authors:  Tamás Dolinay; Young Sam Kim; Judie Howrylak; Gary M Hunninghake; Chang Hyeok An; Laura Fredenburgh; Anthony F Massaro; Angela Rogers; Lee Gazourian; Kiichi Nakahira; Jeffrey A Haspel; Roberto Landazury; Sabitha Eppanapally; Jason D Christie; Nuala J Meyer; Lorraine B Ware; David C Christiani; Stefan W Ryter; Rebecca M Baron; Augustine M K Choi
Journal:  Am J Respir Crit Care Med       Date:  2012-03-29       Impact factor: 21.405

6.  Pentoxifylline inhibits the synthesis and IFN-gamma-inducing activity of IL-18.

Authors:  T Samardzic; V Jankovic; S Stosic-Grujicic; D Popadic; V Trajkovic
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

7.  Inflammatory molecules expression pattern for identifying pathogen species in febrile patient serum.

Authors:  Kuan-Ting Liu; Yao-Hua Liu; Chun-Yu Lin; Po-Lin Kuo; Meng-Chi Yen
Journal:  Exp Ther Med       Date:  2016-05-10       Impact factor: 2.447

8.  Interleukin-18 facilitates the early antimicrobial host response to Escherichia coli peritonitis.

Authors:  Sebastiaan Weijer; Miguel E Sewnath; Alex F de Vos; Sandrine Florquin; Koen van der Sluis; Dirk J Gouma; Kiyoshi Takeda; Shizuo Akira; Tom van der Poll
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

9.  Targeting IL-17A attenuates neonatal sepsis mortality induced by IL-18.

Authors:  James Lawrence Wynn; Chris S Wilson; Jacek Hawiger; Philip O Scumpia; Andrew F Marshall; Jin-Hua Liu; Irina Zharkikh; Hector R Wong; Patrick Lahni; John T Benjamin; Erin J Plosa; Jörn-Hendrik Weitkamp; Edward R Sherwood; Lyle L Moldawer; Ricardo Ungaro; Henry V Baker; M Cecilia Lopez; Steven J McElroy; Natacha Colliou; Mansour Mohamadzadeh; Daniel Jensen Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

10.  MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis.

Authors:  Catalin Vasilescu; Simona Rossi; Masayoshi Shimizu; Stefan Tudor; Angelo Veronese; Manuela Ferracin; Milena S Nicoloso; Elisa Barbarotto; Monica Popa; Oana Stanciulea; Michael H Fernandez; Dan Tulbure; Carlos E Bueso-Ramos; Massimo Negrini; George A Calin
Journal:  PLoS One       Date:  2009-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.